Motley Fool Australia

MGC Pharmaceuticals Ltd (ASX: MXC) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $196.14 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 2.23 billion
Earnings per share -0.014
Dividend per share N/A
Year To Date Return 248.00%
Earnings Yield N/A
Franking N/A

MGC Pharmaceuticals Ltd (ASX: MXC) Latest News

marijuana leaf with upward facing arrow

Why the MGC Pharma (ASX:MXC) share price is 31% higher today

More »

cannabis leaves on a rising line graph representing growth of ASX cannabis shares

Why the MGC Pharma (ASX:MXC) share price is smoking the market today

More »

marijuana leaf with upward facing arrow

Why these ASX cannabis shares are starting the week on a high

More »

marijuana leaf with upward facing arrow

Why this ASX cannabis share jumped 12% higher today

More »

ASX share price growth represented by rising arrow on staircase

Why FAR, Medical Developments, MGC Pharma, & Western Areas are pushing higher

More »

medical marijuana, cannabis, pot, drug, medical

Why this ASX cannabis share is charging higher on Tuesday

More »

Why this ASX cannabis share surged higher today

More »

Buy high, sell low: Canopy Growth Corp dumps Auscann pot stock stake

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About MGC Pharmaceuticals Ltd (ASX: MXC)

MGC Pharmaceuticals Ltd is a biopharma company with a Nature to Medicine strategy within the international phytocannabinoid-derived and plant-derived medicines industry. Its operations comprise one segment, being production and supply of medicinal cannabis products. The company generates most of its revenue from Slovenia.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
26 Feb 2021 $0.09 $-0.01 -10.42% 19,717,185 $0.09 $0.09 $0.09
25 Feb 2021 $0.10 $0.01 11.49% 35,313,811 $0.09 $0.10 $0.09
24 Feb 2021 $0.09 $-0.02 -19.05% 39,398,105 $0.10 $0.10 $0.09
23 Feb 2021 $0.11 $0.00 0.00% 19,451,906 $0.11 $0.11 $0.10
22 Feb 2021 $0.10 $-0.03 -24.00% 32,059,960 $0.11 $0.11 $0.10
19 Feb 2021 $0.13 $0.03 31.58% 150,421,253 $0.13 $0.13 $0.11
18 Feb 2021 $0.10 $0.03 43.48% 108,903,607 $0.08 $0.10 $0.08
17 Feb 2021 $0.07 $-0.01 -12.82% 67,489,423 $0.08 $0.08 $0.06
16 Feb 2021 $0.08 $0.00 0.00% 69,331,191 $0.08 $0.09 $0.07
15 Feb 2021 $0.08 $0.01 15.38% 145,384,247 $0.07 $0.09 $0.07
12 Feb 2021 $0.07 $0.02 42.55% 143,817,940 $0.07 $0.07 $0.06
11 Feb 2021 $0.05 $0.01 24.39% 139,025,904 $0.05 $0.05 $0.05
10 Feb 2021 $0.04 $0.01 27.78% 48,422,439 $0.04 $0.04 $0.04
09 Feb 2021 $0.04 $0.00 0.00% 19,631,220 $0.04 $0.04 $0.03
08 Feb 2021 $0.03 $0.00 0.00% 27,182,934 $0.04 $0.04 $0.03
05 Feb 2021 $0.03 $0.01 35.71% 38,682,620 $0.03 $0.03 $0.03
04 Feb 2021 $0.03 $0.00 0.00% 41,996,355 $0.03 $0.03 $0.03
01 Feb 2021 $0.03 $0.00 0.00% 5,180,719 $0.03 $0.03 $0.03
29 Jan 2021 $0.03 $0.00 0.00% 7,479,303 $0.03 $0.03 $0.03
28 Jan 2021 $0.03 $0.00 0.00% 3,546,378 $0.03 $0.03 $0.03
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
12 Aug 2020 Brett Mitchell Buy 2 $60,000
12 Aug 2020 Brett Mitchell Exercise 2 $60,000
12 Aug 2020 Roby Zomer Buy 2 $60,000
12 Aug 2020 Roby Zomer Exercise 2 $60,000
10 Jul 2020 Ross Walker Issued 185 $740
10 Jul 2020 Brett Mitchell Issued 555 $2,222
18 Mar 2020 Brett Mitchell Buy 1 $30,000
18 Mar 2020 Ross Walker Buy 370 $10,000
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr Evan Hayes Non-Executive Director Sep 2020
Mr Brett Anthony Mitchell Executive Chairman,Executive Director Apr 2013
Dr Ross Grant Thomas Walker Non-Executive Director Feb 2016
Mr Nativ Segev Non-Executive Director Feb 2016
Mr Roby Reuven Zomer Chief Executive Officer,Managing Director Feb 2016
Mr Stephen Barry Parker Non-Executive Director Mar 2019
Ms Narelle Warren Joint Company Secretary Nov 2020
Mrs Rachel Kerr Company Secretary Jan 2018
Rachel Kerr Company Secretary
Narelle Warren Joint Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 120,080,182 7.36%
MGC Pharmaceuticals Ltd 45,993,000 2.82%
Mr George Bishay 36,822,890 2.26%
Citicorp Nominees Pty Limited 30,000,091 1.84%
Mr Brett Mitchell + Mrs Michelle Mitchell <Mitchell Spring Family A/C> 22,264,444 1.36%
C Y T Investment Pty Ltd 14,000,000 0.86%
J P Morgan Nominees Australia Pty Limited 10,167,392 0.62%
Mr Shady Eskander 8,311,111 0.51%
Mr Brett Mitchell + Mrs Michelle Mitchell <Lefthanders Super Fund A/C> 8,140,560 0.50%
Mr David Clement Hobby 8,000,000 0.49%
Mr Benjamin Thomas Langley 7,388,430 0.45%
Fadco Investments Limited 6,772,613 0.42%
Mr Michael Sean Newton 6,500,000 0.40%
Netwealth Investments Limited <Wrap Services A/C> 6,042,727 0.37%
Cardaze Pty Limited <Boyle Family Super Fund A/C> 5,764,059 0.35%
Merrill Lynch (Australia) Nominees Pty Limited 5,616,522 0.34%
J & D Peos Super Pty Ltd <J & D Peos Super Fund A/C> 5,585,262 0.34%
BNP Paribas Noms Pty Ltd <DRP> 5,210,062 0.32%
Cannvalate Pty Ltd 5,139,037 0.32%
Ms Autumn Bloom 5,000,000 0.31%
Show more